| Nov 4 |
Tempus AI GAAP EPS of -$0.46 misses by $0.03, revenue of $180.93M beats by $1.36M
|
| Nov 4 |
Tempus: Q3 Earnings Snapshot
|
| Nov 4 |
Tempus Reports Third Quarter 2024 Results and Agreement to Acquire Ambry Genetics
|
| Nov 4 |
Tempus to Report Third Quarter 2024 Financial Results on November 4
|
| Oct 29 |
Tempus: Attempting To Lead The AI Revolution In Healthcare
|
| Oct 24 |
Tempus to Report Third Quarter 2024 Financial Results on November 7
|
| Oct 22 |
Avacta partners Tempus AI to boost cancer therapy development
|
| Oct 12 |
Tempus AI, Inc (TEM): A Bull Case Theory
|
| Oct 11 |
Australian Vintage re-appoints former CEO after surprise exit in May
|
| Sep 30 |
Tempus Stock Up Following Collaboration Expansion in Oncology R&D
|
